Generation and Application of Directly Reprogrammed Endothelial Cells
Cell-based therapy has emerged as a promising option for treating advanced ischemic cardiovascular disease by inducing vascular regeneration. However, clinical trials with adult cells turned out disappointing in general. As a newer approach, direct reprogramming has emerged to efficiently generate e...
Saved in:
Published in | Korean circulation journal Vol. 52; no. 9; pp. 643 - 658 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
The Korean Society of Cardiology
01.09.2022
대한심장학회 |
Subjects | |
Online Access | Get full text |
ISSN | 1738-5520 1738-5555 1738-5555 |
DOI | 10.4070/kcj.2022.0190 |
Cover
Abstract | Cell-based therapy has emerged as a promising option for treating advanced ischemic cardiovascular disease by inducing vascular regeneration. However, clinical trials with adult cells turned out disappointing in general. As a newer approach, direct reprogramming has emerged to efficiently generate endothelial cells (ECs), which can promote neovascularization and vascular regeneration. This review provides recent updates on the direct endothelial reprogramming. In general, directly reprogrammed ECs can be generated by two approaches: one by transitioning through a plastic intermediate state and the other in a one-step transition without any intermediate states toward pluripotency. Moreover, the methods to deliver reprogramming factors and chemicals for the fate conversion are highlighted. Next, the therapeutic effects of the directly reprogrammed ECs on animal models are reviewed in detail. Other applications using directly reprogrammed ECs, such as tissue engineering and disease modeling, are also discussed. Lastly, the remaining questions and foremost challenges are addressed. |
---|---|
AbstractList | Direct cell reprogramming refers to the conversion of cell identity, without transition through an induced pluripotent state. Owing to the ability to directly reprogram into numerous cell types, this reprogramming strategy has received enormous attention for regenerative therapy. Particularly, direct reprogramming into functional endothelial cells, which are crucial for neovascularization and vascular regeneration, holds promising therapeutic potential for treating patients with ischemic cardiovascular diseases. This review provides a summary of the-state-of-art in direct endothelial reprograming strategies and highlights their potential applications. It also discusses key questions and challenges that will help guiding future research and development of this emerging area. Cell-based therapy has emerged as a promising option for treating advanced ischemic cardiovascular disease by inducing vascular regeneration. However, clinical trials with adult cells turned out disappointing in general. As a newer approach, direct reprogramming has emerged to efficiently generate endothelial cells (ECs), which can promote neovascularization and vascular regeneration. This review provides recent updates on the direct endothelial reprogramming. In general, directly reprogrammed ECs can be generated by two approaches: one by transitioning through a plastic intermediate state and the other in a one-step transition without any intermediate states toward pluripotency. Moreover, the methods to deliver reprogramming factors and chemicals for the fate conversion are highlighted. Next, the therapeutic effects of the directly reprogrammed ECs on animal models are reviewed in detail. Other applications using directly reprogrammed ECs, such as tissue engineering and disease modeling, are also discussed. Lastly, the remaining questions and foremost challenges are addressed. Cell-based therapy has emerged as a promising option for treating advanced ischemic cardiovascular disease by inducing vascular regeneration. However, clinical trials with adult cells turned out disappointing in general. As a newer approach, direct reprogramming has emerged to efficiently generate endothelial cells (ECs), which can promote neovascularization and vascular regeneration. This review provides recent updates on the direct endothelial reprogramming. In general, directly reprogrammed ECs can be generated by two approaches: one by transitioning through a plastic intermediate state and the other in a one-step transition without any intermediate states toward pluripotency. Moreover, the methods to deliver reprogramming factors and chemicals for the fate conversion are highlighted. Next, the therapeutic effects of the directly reprogrammed ECs on animal models are reviewed in detail. Other applications using directly reprogrammed ECs, such as tissue engineering and disease modeling, are also discussed. Lastly, the remaining questions and foremost challenges are addressed. Cell-based therapy has emerged as a promising option for treating advanced ischemic cardiovascular disease by inducing vascular regeneration. However, clinical trials with adult cells turned out disappointing in general. As a newer approach, direct reprogramming has emerged to efficiently generate endothelial cells (ECs), which can promote neovascularization and vascular regeneration. This review provides recent updates on the direct endothelial reprogramming. In general, directly reprogrammed ECs can be generated by two approaches: one by transitioning through a plastic intermediate state and the other in a one-step transition without any intermediate states toward pluripotency. Moreover, the methods to deliver reprogramming factors and chemicals for the fate conversion are highlighted. Next, the therapeutic effects of the directly reprogrammed ECs on animal models are reviewed in detail. Other applications using directly reprogrammed ECs, such as tissue engineering and disease modeling, are also discussed. Lastly, the remaining questions and foremost challenges are addressed. KCI Citation Count: 0 Cell-based therapy has emerged as a promising option for treating advanced ischemic cardiovascular disease by inducing vascular regeneration. However, clinical trials with adult cells turned out disappointing in general. As a newer approach, direct reprogramming has emerged to efficiently generate endothelial cells (ECs), which can promote neovascularization and vascular regeneration. This review provides recent updates on the direct endothelial reprogramming. In general, directly reprogrammed ECs can be generated by two approaches: one by transitioning through a plastic intermediate state and the other in a one-step transition without any intermediate states toward pluripotency. Moreover, the methods to deliver reprogramming factors and chemicals for the fate conversion are highlighted. Next, the therapeutic effects of the directly reprogrammed ECs on animal models are reviewed in detail. Other applications using directly reprogrammed ECs, such as tissue engineering and disease modeling, are also discussed. Lastly, the remaining questions and foremost challenges are addressed.Cell-based therapy has emerged as a promising option for treating advanced ischemic cardiovascular disease by inducing vascular regeneration. However, clinical trials with adult cells turned out disappointing in general. As a newer approach, direct reprogramming has emerged to efficiently generate endothelial cells (ECs), which can promote neovascularization and vascular regeneration. This review provides recent updates on the direct endothelial reprogramming. In general, directly reprogrammed ECs can be generated by two approaches: one by transitioning through a plastic intermediate state and the other in a one-step transition without any intermediate states toward pluripotency. Moreover, the methods to deliver reprogramming factors and chemicals for the fate conversion are highlighted. Next, the therapeutic effects of the directly reprogrammed ECs on animal models are reviewed in detail. Other applications using directly reprogrammed ECs, such as tissue engineering and disease modeling, are also discussed. Lastly, the remaining questions and foremost challenges are addressed. |
Author | Yoon, Young-sup Lee, Sangho Jung, Cholomi Oh, Jee Eun |
AuthorAffiliation | 3 Research and Development Center, KarisBio Inc., Seoul, Korea 4 Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA 1 Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea 2 Department of Internal Medicine, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul , Korea |
AuthorAffiliation_xml | – name: 4 Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA – name: 1 Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea – name: 2 Department of Internal Medicine, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul , Korea – name: 3 Research and Development Center, KarisBio Inc., Seoul, Korea |
Author_xml | – sequence: 1 givenname: Cholomi orcidid: 0000-0001-9067-3724 surname: Jung fullname: Jung, Cholomi organization: Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea., Department of Internal Medicine, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Korea – sequence: 2 givenname: Jee Eun orcidid: 0000-0002-3469-8545 surname: Oh fullname: Oh, Jee Eun organization: Research and Development Center, KarisBio Inc., Seoul, Korea – sequence: 3 givenname: Sangho orcidid: 0000-0003-3771-7761 surname: Lee fullname: Lee, Sangho organization: Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA – sequence: 4 givenname: Young-sup orcidid: 0000-0003-0051-0935 surname: Yoon fullname: Yoon, Young-sup organization: Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea., Research and Development Center, KarisBio Inc., Seoul, Korea., Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36097834$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002875233$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNqFkdtLHDEUxoNY6qV99FXmsRRmm9vk8lJY1q0KQkHsc8hkM5rdbDIms8r-9806VltBmpeTkN93vpMvR2A_xGABOEFwQiGH31ZmOcEQ4wlEEu6BQ8SJqJuy9l_2GB6Ao5yXEDJKsfwIDgiDkgtCD8H83Aab9OBiqHRYVNO-986M59hVZy5ZM_htdW37FG-TXq_topqHRRzurHfaVzPrff4EPnTaZ_v5uR6DXz_mN7OL-urn-eVselUbivFQ45a1jbDMSLZoGDVEEKERbQS0jFFmIeVYUGk44ox3VsqGtcZIgghGTSdacgy-jn1D6tTKOBW1e6q3Ua2Sml7fXCoEYQkGwQJPRngTer191N6rPrm1TtvCqF14RbpUu_DULrwi-D4K-k1bnmlsGJJ-Fe28_r0J7q44PyhJOaRClgZfnhukeL-xeVBrl00JSAcbN1lhjihkDcaooKd_e72Y_PmZAtQjYFLMOdnuv8OTN7xxw9M_llGdf0f1G6NKrxE |
CitedBy_id | crossref_primary_10_1038_s41580_024_00825_w |
Cites_doi | 10.1038/nature08797 10.4070/kcj.2021.0291 10.1016/j.stem.2007.05.014 10.1126/science.1151526 10.1016/j.gpb.2013.09.001 10.1161/ATVBAHA.118.311919 10.1161/CIRCULATIONAHA.113.007394 10.1038/s41401-018-0170-z 10.3390/jcdd8110148 10.1038/s41551-021-00783-0 10.1016/j.stem.2013.05.016 10.1161/01.ATV.17.7.1193 10.1161/CIRCULATIONAHA.116.026329 10.1186/s13395-016-0103-9 10.1038/nature09591 10.1056/NEJMcp1709326 10.1177/2041731416628329 10.1136/heartjnl-2018-313103 10.1016/j.stem.2016.08.019 10.1073/pnas.1205526109 10.1161/CIRCULATIONAHA.107.759480 10.1038/nprot.2012.115 10.1016/j.stem.2013.05.011 10.1186/s13287-018-0932-z 10.1073/pnas.1413234112 10.1016/j.cell.2015.02.035 10.1016/j.ijcard.2017.01.125 10.1164/rccm.201606-1200OC 10.1038/srep18865 10.1182/blood-2002-07-2314 10.2183/pjab.96.012 10.1161/CIR.0000000000000950 10.1016/j.cell.2010.07.002 10.1038/nmeth.2255 10.1038/nature10202 10.1016/j.cell.2007.11.019 10.1016/j.stem.2016.05.005 10.1126/science.1172482 10.1038/nature10263 10.4070/kcj.2022.0005 10.1126/science.1068893 10.1084/jem.20070166 10.1038/nmeth.2331 10.1038/nature07314 10.1161/ATVBAHA.112.301167 10.1016/j.cell.2016.11.033 10.1038/nbt1287 10.1186/s13287-018-1088-6 10.1016/j.ymthe.2019.11.019 10.1161/ATVBAHA.111.230938 10.1161/CIRCULATIONAHA.113.007727 10.1161/ATVBAHA.108.182162 10.1161/CIRCRESAHA.116.309833 10.7554/eLife.54383 10.1126/science.1164270 10.1371/journal.pone.0057876 10.1016/j.cell.2012.09.032 10.1016/j.neuroscience.2018.03.033 10.1007/s12015-018-9805-1 10.1016/j.biomaterials.2021.120781 10.1016/j.stem.2015.05.004 10.1126/sciadv.aba7606 10.1016/j.devcel.2013.06.017 10.4070/kcj.2022.0064 10.1152/ajpcell.00057.2014 10.1038/s41598-017-05665-7 10.1161/CIRCULATIONAHA.119.041433 |
ContentType | Journal Article |
Copyright | Copyright © 2022. The Korean Society of Cardiology. Copyright © 2022. The Korean Society of Cardiology 2022 The Korean Society of Cardiology |
Copyright_xml | – notice: Copyright © 2022. The Korean Society of Cardiology. – notice: Copyright © 2022. The Korean Society of Cardiology 2022 The Korean Society of Cardiology |
DBID | AAYXX CITATION NPM 7X8 5PM ADTOC UNPAY ACYCR |
DOI | 10.4070/kcj.2022.0190 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall Korean Citation Index |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1738-5555 |
EndPage | 658 |
ExternalDocumentID | oai_kci_go_kr_ARTI_10040710 10.4070/kcj.2022.0190 PMC9470489 36097834 10_4070_kcj_2022_0190 |
Genre | Journal Article Review |
GrantInformation_xml | – fundername: AHA Transformational Project Award grantid: 20TPA35490282 – fundername: Korea Health Industry Development Institute grantid: HV22C0138 – fundername: NHLBI NIH HHS grantid: R01HL150877 – fundername: Yonsei University College of Medicine grantid: 6-2021-0178 – fundername: National Research Foundation of Korea grantid: 2020R1A2C3003784 – fundername: NIEHS NIH HHS grantid: 27302C0138 – fundername: National Research Foundation of Korea grantid: 2020M3A9I4038454 – fundername: Ministry of Trade, Industry and Energy grantid: 20016564 – fundername: AHA Career Development Award grantid: 19CDA34760061 – fundername: ; grantid: 19CDA34760061 – fundername: ; grantid: 2020R1A2C3003784; 2020M3A9I4038454 – fundername: ; grantid: 20TPA35490282 – fundername: ; grantid: 20016564 – fundername: ; grantid: HV22C0138 – fundername: ; grantid: R01HL150877 – fundername: ; grantid: 6-2021-0178 |
GroupedDBID | --- 5-W 8JR 8XY 9ZL AAYXX ADBBV ADRAZ AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION DIK E3Z EF. F5P HYE KQ8 M48 O5R O5S OK1 PGMZT RPM NPM 7X8 5PM ADTOC UNPAY ACYCR M~E |
ID | FETCH-LOGICAL-c422t-2b6b58e6c96d564c3838a14580e6646e0472849c71767fe9956bcc9313215f8b3 |
IEDL.DBID | UNPAY |
ISSN | 1738-5520 1738-5555 |
IngestDate | Tue Nov 21 21:39:09 EST 2023 Wed Aug 20 00:20:41 EDT 2025 Tue Sep 30 16:55:17 EDT 2025 Fri Jul 11 10:59:27 EDT 2025 Thu Apr 03 07:03:58 EDT 2025 Thu Apr 24 22:58:27 EDT 2025 Tue Jul 01 01:12:13 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | Cell differentiation and regenerative medicine Cardiovascular disease Neovascularization Direct cell reprogramming Endothelial cells |
Language | English |
License | Copyright © 2022. The Korean Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. cc-by-nc |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c422t-2b6b58e6c96d564c3838a14580e6646e0472849c71767fe9956bcc9313215f8b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 Cholomi Jung and Jee Eun Oh contributed equally to this work. https://doi.org/10.4070/kcj.2022.0190 |
ORCID | 0000-0001-9067-3724 0000-0003-3771-7761 0000-0003-0051-0935 0000-0002-3469-8545 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=http://e-kcj.org/Synapse/Data/PDFData/0054KCJ/kcj-52-643.pdf |
PMID | 36097834 |
PQID | 2714065221 |
PQPubID | 23479 |
PageCount | 16 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_10040710 unpaywall_primary_10_4070_kcj_2022_0190 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9470489 proquest_miscellaneous_2714065221 pubmed_primary_36097834 crossref_primary_10_4070_kcj_2022_0190 crossref_citationtrail_10_4070_kcj_2022_0190 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-09-01 |
PublicationDateYYYYMMDD | 2022-09-01 |
PublicationDate_xml | – month: 09 year: 2022 text: 2022-09-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Korean circulation journal |
PublicationTitleAlternate | Korean Circ J |
PublicationYear | 2022 |
Publisher | The Korean Society of Cardiology 대한심장학회 |
Publisher_xml | – name: The Korean Society of Cardiology – name: 대한심장학회 |
References | Yu (10.4070/kcj.2022.0190_ref6) 2007; 318 Taura (10.4070/kcj.2022.0190_ref8) 2009; 29 Wong (10.4070/kcj.2022.0190_ref26) 2016; 7 Lee (10.4070/kcj.2022.0190_ref27) 2017; 120 Sekiya (10.4070/kcj.2022.0190_ref17) 2011; 475 Zhou (10.4070/kcj.2022.0190_ref40) 2012; 7 Li (10.4070/kcj.2022.0190_ref59) 2002; 296 Ginsberg (10.4070/kcj.2022.0190_ref20) 2012; 151 Theodoris (10.4070/kcj.2022.0190_ref51) 2015; 160 van der Bogt (10.4070/kcj.2022.0190_ref63) 2008; 118 Li (10.4070/kcj.2022.0190_ref38) 2021; 30 Gu (10.4070/kcj.2022.0190_ref48) 2017; 20 Li (10.4070/kcj.2022.0190_ref23) 2013; 33 Ranzani (10.4070/kcj.2022.0190_ref58) 2013; 10 Oh (10.4070/kcj.2022.0190_ref65) 2021; 8 Wang (10.4070/kcj.2022.0190_ref7) 2007; 25 Yu (10.4070/kcj.2022.0190_ref35) 2009; 324 Zhou (10.4070/kcj.2022.0190_ref13) 2008; 455 Sayed (10.4070/kcj.2022.0190_ref37) 2015; 131 Takahashi (10.4070/kcj.2022.0190_ref5) 2007; 131 Margariti (10.4070/kcj.2022.0190_ref21) 2012; 109 Ieda (10.4070/kcj.2022.0190_ref15) 2010; 142 Cho (10.4070/kcj.2022.0190_ref36) 2021; 5 Horisawa (10.4070/kcj.2022.0190_ref45) 2020; 96 Virani (10.4070/kcj.2022.0190_ref1) 2021; 143 Han (10.4070/kcj.2022.0190_ref24) 2014; 130 Vasu (10.4070/kcj.2022.0190_ref64) 2021; 51 Maherali (10.4070/kcj.2022.0190_ref54) 2007; 1 Kim (10.4070/kcj.2022.0190_ref30) 2020; 28 Engle (10.4070/kcj.2022.0190_ref46) 2013; 12 Okita (10.4070/kcj.2022.0190_ref34) 2008; 322 Rezvani (10.4070/kcj.2022.0190_ref33) 2016; 18 West (10.4070/kcj.2022.0190_ref50) 2014; 307 Farber (10.4070/kcj.2022.0190_ref3) 2018; 379 Lai (10.4070/kcj.2022.0190_ref12) 2013; 8 Zhang (10.4070/kcj.2022.0190_ref41) 2013; 11 Vierbuchen (10.4070/kcj.2022.0190_ref14) 2010; 463 Pavathuparambil Abdul Manaph (10.4070/kcj.2022.0190_ref39) 2018; 9 Clayton (10.4070/kcj.2022.0190_ref11) 2017; 234 Lee (10.4070/kcj.2022.0190_ref19) 2022; 52 Cho (10.4070/kcj.2022.0190_ref62) 2007; 204 Wu (10.4070/kcj.2022.0190_ref52) 2016; 6 Merkle (10.4070/kcj.2022.0190_ref47) 2013; 12 Tang (10.4070/kcj.2022.0190_ref43) 2019; 40 Sa (10.4070/kcj.2022.0190_ref49) 2017; 195 Bersini (10.4070/kcj.2022.0190_ref31) 2020; 9 Ang (10.4070/kcj.2022.0190_ref53) 2016; 167 Garlanda (10.4070/kcj.2022.0190_ref66) 1997; 17 Suknuntha (10.4070/kcj.2022.0190_ref60) 2018; 14 Kim (10.4070/kcj.2022.0190_ref42) 2016; 6 Cheng (10.4070/kcj.2022.0190_ref28) 2018; 9 Han (10.4070/kcj.2022.0190_ref32) 2021; 272 Baum (10.4070/kcj.2022.0190_ref57) 2003; 101 Paik (10.4070/kcj.2022.0190_ref67) 2020; 142 Kurian (10.4070/kcj.2022.0190_ref22) 2013; 10 Rufaihah (10.4070/kcj.2022.0190_ref9) 2011; 31 Pang (10.4070/kcj.2022.0190_ref18) 2011; 476 Studer (10.4070/kcj.2022.0190_ref55) 2015; 16 Szabo (10.4070/kcj.2022.0190_ref16) 2010; 468 Morita (10.4070/kcj.2022.0190_ref25) 2015; 112 Kim (10.4070/kcj.2022.0190_ref4) 2022; 52 Chen (10.4070/kcj.2022.0190_ref29) 2019; 39 Hong (10.4070/kcj.2022.0190_ref56) 2017; 7 Wang (10.4070/kcj.2022.0190_ref61) 2020; 6 Lee (10.4070/kcj.2022.0190_ref10) 2017; 136 Nolan (10.4070/kcj.2022.0190_ref68) 2013; 26 Bhagra (10.4070/kcj.2022.0190_ref2) 2019; 105 Omrani (10.4070/kcj.2022.0190_ref44) 2018; 380 |
References_xml | – volume: 463 start-page: 1035 year: 2010 ident: 10.4070/kcj.2022.0190_ref14 publication-title: Nature doi: 10.1038/nature08797 – volume: 51 start-page: 943 year: 2021 ident: 10.4070/kcj.2022.0190_ref64 publication-title: Korean Circ J doi: 10.4070/kcj.2021.0291 – volume: 1 start-page: 55 year: 2007 ident: 10.4070/kcj.2022.0190_ref54 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2007.05.014 – volume: 318 start-page: 1917 year: 2007 ident: 10.4070/kcj.2022.0190_ref6 publication-title: Science doi: 10.1126/science.1151526 – volume: 11 start-page: 264 year: 2013 ident: 10.4070/kcj.2022.0190_ref41 publication-title: Genomics Proteomics Bioinformatics doi: 10.1016/j.gpb.2013.09.001 – volume: 39 start-page: 765 year: 2019 ident: 10.4070/kcj.2022.0190_ref29 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.118.311919 – volume: 131 start-page: 300 year: 2015 ident: 10.4070/kcj.2022.0190_ref37 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.113.007394 – volume: 40 start-page: 620 year: 2019 ident: 10.4070/kcj.2022.0190_ref43 publication-title: Acta Pharmacol Sin doi: 10.1038/s41401-018-0170-z – volume: 8 start-page: 148 year: 2021 ident: 10.4070/kcj.2022.0190_ref65 publication-title: J Cardiovasc Dev Dis doi: 10.3390/jcdd8110148 – volume: 5 start-page: 880 year: 2021 ident: 10.4070/kcj.2022.0190_ref36 publication-title: Nat Biomed Eng doi: 10.1038/s41551-021-00783-0 – volume: 12 start-page: 656 year: 2013 ident: 10.4070/kcj.2022.0190_ref47 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2013.05.016 – volume: 17 start-page: 1193 year: 1997 ident: 10.4070/kcj.2022.0190_ref66 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.17.7.1193 – volume: 136 start-page: 1939 year: 2017 ident: 10.4070/kcj.2022.0190_ref10 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.116.026329 – volume: 6 start-page: 32 year: 2016 ident: 10.4070/kcj.2022.0190_ref42 publication-title: Skelet Muscle doi: 10.1186/s13395-016-0103-9 – volume: 468 start-page: 521 year: 2010 ident: 10.4070/kcj.2022.0190_ref16 publication-title: Nature doi: 10.1038/nature09591 – volume: 379 start-page: 171 year: 2018 ident: 10.4070/kcj.2022.0190_ref3 publication-title: N Engl J Med doi: 10.1056/NEJMcp1709326 – volume: 7 start-page: 2041731416628329 year: 2016 ident: 10.4070/kcj.2022.0190_ref26 publication-title: J Tissue Eng doi: 10.1177/2041731416628329 – volume: 105 start-page: 252 year: 2019 ident: 10.4070/kcj.2022.0190_ref2 publication-title: Heart doi: 10.1136/heartjnl-2018-313103 – volume: 20 start-page: 490 year: 2017 ident: 10.4070/kcj.2022.0190_ref48 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2016.08.019 – volume: 109 start-page: 13793 year: 2012 ident: 10.4070/kcj.2022.0190_ref21 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1205526109 – volume: 118 start-page: S121 year: 2008 ident: 10.4070/kcj.2022.0190_ref63 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.107.759480 – volume: 7 start-page: 2080 year: 2012 ident: 10.4070/kcj.2022.0190_ref40 publication-title: Nat Protoc doi: 10.1038/nprot.2012.115 – volume: 12 start-page: 669 year: 2013 ident: 10.4070/kcj.2022.0190_ref46 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2013.05.011 – volume: 9 start-page: 189 year: 2018 ident: 10.4070/kcj.2022.0190_ref39 publication-title: Stem Cell Res Ther doi: 10.1186/s13287-018-0932-z – volume: 112 start-page: 160 year: 2015 ident: 10.4070/kcj.2022.0190_ref25 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1413234112 – volume: 160 start-page: 1072 year: 2015 ident: 10.4070/kcj.2022.0190_ref51 publication-title: Cell doi: 10.1016/j.cell.2015.02.035 – volume: 234 start-page: 81 year: 2017 ident: 10.4070/kcj.2022.0190_ref11 publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2017.01.125 – volume: 195 start-page: 930 year: 2017 ident: 10.4070/kcj.2022.0190_ref49 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201606-1200OC – volume: 6 start-page: 18865 year: 2016 ident: 10.4070/kcj.2022.0190_ref52 publication-title: Sci Rep doi: 10.1038/srep18865 – volume: 101 start-page: 2099 year: 2003 ident: 10.4070/kcj.2022.0190_ref57 publication-title: Blood doi: 10.1182/blood-2002-07-2314 – volume: 96 start-page: 131 year: 2020 ident: 10.4070/kcj.2022.0190_ref45 publication-title: Proc Jpn Acad Ser B Phys Biol Sci doi: 10.2183/pjab.96.012 – volume: 143 start-page: e254 year: 2021 ident: 10.4070/kcj.2022.0190_ref1 publication-title: Circulation doi: 10.1161/CIR.0000000000000950 – volume: 142 start-page: 375 year: 2010 ident: 10.4070/kcj.2022.0190_ref15 publication-title: Cell doi: 10.1016/j.cell.2010.07.002 – volume: 10 start-page: 77 year: 2013 ident: 10.4070/kcj.2022.0190_ref22 publication-title: Nat Methods doi: 10.1038/nmeth.2255 – volume: 476 start-page: 220 year: 2011 ident: 10.4070/kcj.2022.0190_ref18 publication-title: Nature doi: 10.1038/nature10202 – volume: 131 start-page: 861 year: 2007 ident: 10.4070/kcj.2022.0190_ref5 publication-title: Cell doi: 10.1016/j.cell.2007.11.019 – volume: 18 start-page: 809 year: 2016 ident: 10.4070/kcj.2022.0190_ref33 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2016.05.005 – volume: 324 start-page: 797 year: 2009 ident: 10.4070/kcj.2022.0190_ref35 publication-title: Science doi: 10.1126/science.1172482 – volume: 475 start-page: 390 year: 2011 ident: 10.4070/kcj.2022.0190_ref17 publication-title: Nature doi: 10.1038/nature10263 – volume: 52 start-page: 341 year: 2022 ident: 10.4070/kcj.2022.0190_ref19 publication-title: Korean Circ J doi: 10.4070/kcj.2022.0005 – volume: 296 start-page: 497 year: 2002 ident: 10.4070/kcj.2022.0190_ref59 publication-title: Science doi: 10.1126/science.1068893 – volume: 204 start-page: 3257 year: 2007 ident: 10.4070/kcj.2022.0190_ref62 publication-title: J Exp Med doi: 10.1084/jem.20070166 – volume: 10 start-page: 155 year: 2013 ident: 10.4070/kcj.2022.0190_ref58 publication-title: Nat Methods doi: 10.1038/nmeth.2331 – volume: 455 start-page: 627 year: 2008 ident: 10.4070/kcj.2022.0190_ref13 publication-title: Nature doi: 10.1038/nature07314 – volume: 33 start-page: 1366 year: 2013 ident: 10.4070/kcj.2022.0190_ref23 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.112.301167 – volume: 167 start-page: 1734 year: 2016 ident: 10.4070/kcj.2022.0190_ref53 publication-title: Cell doi: 10.1016/j.cell.2016.11.033 – volume: 25 start-page: 317 year: 2007 ident: 10.4070/kcj.2022.0190_ref7 publication-title: Nat Biotechnol doi: 10.1038/nbt1287 – volume: 9 start-page: 350 year: 2018 ident: 10.4070/kcj.2022.0190_ref28 publication-title: Stem Cell Res Ther doi: 10.1186/s13287-018-1088-6 – volume: 28 start-page: 466 year: 2020 ident: 10.4070/kcj.2022.0190_ref30 publication-title: Mol Ther doi: 10.1016/j.ymthe.2019.11.019 – volume: 31 start-page: e72 year: 2011 ident: 10.4070/kcj.2022.0190_ref9 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.111.230938 – volume: 130 start-page: 1168 year: 2014 ident: 10.4070/kcj.2022.0190_ref24 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.113.007727 – volume: 29 start-page: 1100 year: 2009 ident: 10.4070/kcj.2022.0190_ref8 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.108.182162 – volume: 120 start-page: 848 year: 2017 ident: 10.4070/kcj.2022.0190_ref27 publication-title: Circ Res doi: 10.1161/CIRCRESAHA.116.309833 – volume: 9 start-page: e54383 year: 2020 ident: 10.4070/kcj.2022.0190_ref31 publication-title: eLife doi: 10.7554/eLife.54383 – volume: 322 start-page: 949 year: 2008 ident: 10.4070/kcj.2022.0190_ref34 publication-title: Science doi: 10.1126/science.1164270 – volume: 30 start-page: 963689720978739 year: 2021 ident: 10.4070/kcj.2022.0190_ref38 publication-title: Cell Transplant – volume: 8 start-page: e57876 year: 2013 ident: 10.4070/kcj.2022.0190_ref12 publication-title: PLoS One doi: 10.1371/journal.pone.0057876 – volume: 151 start-page: 559 year: 2012 ident: 10.4070/kcj.2022.0190_ref20 publication-title: Cell doi: 10.1016/j.cell.2012.09.032 – volume: 380 start-page: 63 year: 2018 ident: 10.4070/kcj.2022.0190_ref44 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2018.03.033 – volume: 14 start-page: 525 year: 2018 ident: 10.4070/kcj.2022.0190_ref60 publication-title: Stem Cell Rev Rep doi: 10.1007/s12015-018-9805-1 – volume: 272 start-page: 120781 year: 2021 ident: 10.4070/kcj.2022.0190_ref32 publication-title: Biomaterials doi: 10.1016/j.biomaterials.2021.120781 – volume: 16 start-page: 591 year: 2015 ident: 10.4070/kcj.2022.0190_ref55 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2015.05.004 – volume: 6 start-page: eaba7606 year: 2020 ident: 10.4070/kcj.2022.0190_ref61 publication-title: Sci Adv doi: 10.1126/sciadv.aba7606 – volume: 26 start-page: 204 year: 2013 ident: 10.4070/kcj.2022.0190_ref68 publication-title: Dev Cell doi: 10.1016/j.devcel.2013.06.017 – volume: 52 start-page: 441 year: 2022 ident: 10.4070/kcj.2022.0190_ref4 publication-title: Korean Circ J doi: 10.4070/kcj.2022.0064 – volume: 307 start-page: C415 year: 2014 ident: 10.4070/kcj.2022.0190_ref50 publication-title: Am J Physiol Cell Physiol doi: 10.1152/ajpcell.00057.2014 – volume: 7 start-page: 5590 year: 2017 ident: 10.4070/kcj.2022.0190_ref56 publication-title: Sci Rep doi: 10.1038/s41598-017-05665-7 – volume: 142 start-page: 1848 year: 2020 ident: 10.4070/kcj.2022.0190_ref67 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.119.041433 |
SSID | ssj0064429 |
Score | 2.2499094 |
SecondaryResourceType | review_article |
Snippet | Cell-based therapy has emerged as a promising option for treating advanced ischemic cardiovascular disease by inducing vascular regeneration. However, clinical... Direct cell reprogramming refers to the conversion of cell identity, without transition through an induced pluripotent state. Owing to the ability to directly... |
SourceID | nrf unpaywall pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 643 |
SubjectTerms | State of the Art Review 내과학 |
SummonAdditionalLinks | – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dS8MwEA9OQX0Rv51fRBR9sbNL06x9EhkTFeaTg72FJk39KpnuA91_793aVcem-NKW9krau0vudyT3CyEnxvMSDyKXw7USDudx5ISBFzkuU8wVSRglBuudm_fipsXv2n77m1IoV2BvZmqH-0m1umnl8314CR0e8GsF0hH34lW_QKLHWAXroktkAYISQwdv8mJCAaL-aMOyag36t-8zN6PbnH59IjyVbDeZhTynF1AuDexbNPyI0vRHdLpeJSs5rKRXmR-skTlj18liM5843yCNjF4arUAjG9Or73lr2kloNvClQwp4PFuwBc3Sho2xPisFF6V1k6a9TdK6bjzUb5x8BwVHc8b6DlNC-YEROhSxL7iGdDSIqtwPXCMEFwapIgMeasjpRC0xWOWqtA6RzrHqJ4Hytsi87VizQyj0daNNAnCMAwjRYErtw0FopWCMiHmZnI8VJ3VOL467XKQS0gzUswQ9S9SzRD2XyWkh_pbxavwmeAxWgHvPEpmw8fzYka9dCXj_FhmXMSMFqaOxlST0D5z0iKzpDHqSISOhAJRZLZPtzGpFg54YVbHAt9cm7FkIYIuTT-zz04iDO-Q1GPvCMjkrLP_3f-z-94f3yDJeZ-vY9sl8vzswBwB8-upw5NJfcGz9ow priority: 102 providerName: Scholars Portal |
Title | Generation and Application of Directly Reprogrammed Endothelial Cells |
URI | https://www.ncbi.nlm.nih.gov/pubmed/36097834 https://www.proquest.com/docview/2714065221 https://pubmed.ncbi.nlm.nih.gov/PMC9470489 http://e-kcj.org/Synapse/Data/PDFData/0054KCJ/kcj-52-643.pdf https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002875233 |
UnpaywallVersion | publishedVersion |
Volume | 52 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Korean Circulation Journal, 2022, 52(9), , pp.643-658 |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1738-5555 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0064429 issn: 1738-5520 databaseCode: KQ8 dateStart: 20090101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1738-5555 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0064429 issn: 1738-5520 databaseCode: DIK dateStart: 20050101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVERR databaseName: KoreaMed Open Access customDbUrl: eissn: 1738-5555 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0064429 issn: 1738-5520 databaseCode: 5-W dateStart: 20050101 isFulltext: true titleUrlDefault: https://koreamed.org/journals providerName: Korean Association of Medical Journal Editors – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1738-5555 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0064429 issn: 1738-5520 databaseCode: RPM dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1738-5555 dateEnd: 20250331 omitProxy: true ssIdentifier: ssj0064429 issn: 1738-5520 databaseCode: M48 dateStart: 20090301 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-tnQS8jM9B-ZiCQPBC2jSx3eSx6lqNoU6ToNJ4QJbtODAauVWbaip_PXdJ2lENEOIltpJTHOfOvjvd3c8Ar20UZRFqLp8ZLXzGUuUncaT8INRhILJEZZbqncdn4mTCTi_4xR5sjlW0_tR8LwP4H9dOzZe2c6wK1Tk_HpUtGRgfBqcdJEIPykdt2p6nWQP2BYWXmrA_OTvvfy5rIHEdcx4G133OK4hN9GACegH6hmHYplLqHZXUcIvsd9bmzaTJ2ys3V-srlee_aKTRXfiyqeupElGm7VWh2-bHTZjH_5rsPTioTVWvX8nWfdiz7gHcGtfB-IcwrCCribOecqnXv46Fe7PMqzbTfO2hjV8lgeG0vKFLqeYrR7H3BjbPl49gMhp-Gpz49akMvmFhWPihFprHVphEpFwwgy5urLqMx4EVgglL8JMxSwz6iaKXWaqc1cYkBBHZ5Vmso0NoupmzT8DD_cMam6GJx9CwMSgehuNFGK1x30lZC95tGCNNDVlOJ2fkEl0X4qPEfyOJj5L42II3W_J5hdXxJ8JXyGW8dykJXZvarzM5XUj0Id4TijN5uUj1ciMFEtccBVKUs7PVUoaEcijQcu224HElFdsBI1FWxuC393bkZUtAI-4-cZffSlzvhPVwP01a8HYrWX-fx9N_pnwGd6hfJcc9h2axWNkXaE0V-ggaYxYf1UvnJ3hOGUU |
linkProvider | Unpaywall |
linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED9tnQS88P1RvhQEghfcpontJo9V12oMbZoElcYDsmzHgdHIrdpUqPz13CVpRzVAiJfYSk5xnDv77nR3PwO8cnGcx6i5GLdGMs4zzdIk1iyMTBTKPNW5o3rnk1N5NOHH5-J8DzbHKjo2td-qAP6Htdfzpese6lJ3zw7HVUsGxvvhcReJ0INiqE078yzfhwNJ4aUWHExOzwafqhpIXMdCROFlX4gaYhM9mJBegL5hFHWolHpHJe37Rf47a_Nq0uT1lZ_r9XddFL9opPEt-Lyp66kTUaadVWk69sdVmMf_muxtuNmYqsGglq07sOf8Xbh20gTj78GohqwmzgbaZ8HgMhYezPKg3kyLdYA2fp0EhtMKRj6jmq8CxT4YuqJY3ofJePRxeMSaUxmY5VFUsshIIxInbSozIblFFzfRPS6S0EnJpSP4yYSnFv1E2c8dVc4aa1OCiOyJPDHxA2j5mXePIMD9w1mXo4nH0bCxKB5W4EVaY3DfyXgb3m4Yo2wDWU4nZxQKXRfio8J_o4iPivjYhtdb8nmN1fEnwpfIZbx3oQhdm9ovMzVdKPQh3hGKM3m5SPViIwUK1xwFUrR3s9VSRYRyKNFy7bXhYS0V2wFjWVXG4Lf3d-RlS0Aj7j7xF18rXO-U93E_TdvwZitZf5_H43-mfAI3qF8nxz2FVrlYuWdoTZXmebNofgLmxhhr |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Generation+and+Application+of+Directly+Reprogrammed+Endothelial+Cells&rft.jtitle=Korean+circulation+journal&rft.au=Jung%2C+Cholomi&rft.au=Oh%2C+Jee+Eun&rft.au=Lee%2C+Sangho&rft.au=Yoon%2C+Young-sup&rft.date=2022-09-01&rft.issn=1738-5520&rft.eissn=1738-5555&rft.volume=52&rft.issue=9&rft.spage=643&rft_id=info:doi/10.4070%2Fkcj.2022.0190&rft.externalDBID=n%2Fa&rft.externalDocID=10_4070_kcj_2022_0190 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1738-5520&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1738-5520&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1738-5520&client=summon |